In vitro efficacy of the combination of ciprofloxacin and cefotaxime against nalidixic acid-resistant Salmonella enterica serotype Typhi

International Journal of Antimicrobial Agents

Volumn 36, Issue 2, 2010, Pages 155-158

  Kim, Dong Min ^a   Neupane, Ganesh Prasad ^a   Jang, Sook Jin ^a   Kim, Sung Hun ^b   Lee, Bok Kwon ^b  

^a Chosun University College of Medicine   (South Korea)

^b Korea National Institute of Health   (South Korea)

Author keywords

Azithromycin; Cefotaxime; Ciprofloxacin; Salmonella Typhi; Typhoid fever

Indexed keywords

AZITHROMYCIN; CEFOTAXIME; CIPROFLOXACIN; NALIDIXIC ACID;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERICIDAL ACTIVITY; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; GYRA GENE; GYRB GENE; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PARC GENE; PARE GENE; PRIORITY JOURNAL; SALMONELLA TYPHI;

ANTI-INFECTIVE AGENTS; CEFOTAXIME; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; DRUG SYNERGISM; HUMANS; MICROBIAL SENSITIVITY TESTS; NALIDIXIC ACID; SALMONELLA TYPHI; TYPHOID FEVER;

EID: 77953809306     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.03.022     Document Type: Article

References (15)

1. Parry C.M., Ho V.A., Phuong le T., Bay P.V., Lanh M.N., Tung L.T., et al. Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever. Antimicrob Agents Chemother 2007, 51:819-825.
2. Chau T.T., Campbell J.I., Galindo C.M., Van Minh Hoang N., Diep T.S., Nga T.T.T., et al. Antimicrobial drug resistance of Salmonella enterica serovar Typhi in Asia and molecular mechanism of reduced susceptibility to the fluoroquinolones. Antimicrob Agents Chemother 2007, 51:4315-4323.
3. Kariuki S., Revathi G., Muyodi J., Mwituria J., Munyalo A., Mirza S., et al. Characterization of multidrug-resistant typhoid outbreaks in Kenya. J Clin Microbiol 2004, 42:1477-1482.
4. Capoor M.R., Nair D., Aggarwal P., Mathys V., Dehem M., Bifani P.J. Salmonella enterica serovar Typhi: molecular analysis of strains with decreased susceptibility and resistant to ciprofloxacin in India from 2001-2003. Braz J Infect Dis 2007, 11:423-425.
5. Dutta P., Mitra U., Dutta S., De A., Chatterjee M.K., Bhattacharya S.K. Ceftriaxone therapy in ciprofloxacin treatment failure typhoid fever in children. Indian J Med Res 2001, 113:210-213.
6. Basnyat B., Maskey A.P., Zimmerman M.D., Murdoch D.R. Enteric (typhoid) fever in travelers. Clin Infect Dis 2005, 41:1467-1472.
7. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Eighteenth informational supplement. Document M100-S18. Wayne, PA: CLSI; 2008.
8. Kim D.M., Lym Y., Jang S.J., Han H., Kim Y.G., Chung C.H., et al. In vitro efficacy of the combination of ciprofloxacin and cefotaxime against Vibrio vulnificus. Antimicrob Agents Chemother 2005, 49:3489-3491.
9. Vidaillac C., Leonard S.N., Sader H.S., Jones R.N., Rybak M.J. In vitro activity of ceftaroline alone and in combination against clinical isolates of resistant Gram-negative pathogens, including β-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob Agents Chemother 2009, 53:2360-2366.
10. Hopkins K.L., Davies R.H., Threlfall E.J. Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments. Int J Antimicrob Agents 2005, 25:358-373.
11. Wain J., Hoa N.T., Chinh N.T., Vinh H., Everett M.J., Diep T.S., et al. Quinolone-resistant Salmonella Typhi in Viet Nam: molecular basis of resistance and clinical response to treatment. Clin Infect Dis 1997, 25:1404-1410.
12. Parry C., Wain J., Chinh N.T., Vinh H., Farrar J.J. Quinolone-resistant Salmonella Typhi in Vietnam. Lancet 1998, 351:1289.
13. Saha S.K., Talukder S.Y., Islam M., Saha S. A highly ceftriaxone-resistant Salmonella Typhi in Bangladesh. Pediatr Infect Dis J 1999, 18:387.
14. Butler T., Frenck R.W., Johnson R.B., Khakhria R. In vitro effects of azithromycin on Salmonella Typhi: early inhibition by concentrations less than the MIC and reduction of MIC by alkaline pH and small inocula. J Antimicrob Chemother 2001, 47:455-458.
15. Butler T. Reduction of MIC of azithromycin for Salmonella Typhi and Staphylococcus aureus in broth exposed to previous growth of Salmonella Typhi. J Antimicrob Chemother 2002, 50:143-145.